Compare EOG Resources Inc (EOG) vs Globus Medical Inc. Class A Common Stock (GMED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EOG Resources Inc vs Globus Medical Inc. Class A Common Stock — how do they compare? EOG Resources Inc trades at $155 (market cap $80.88B), while Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B). The key difference: EOG Resources Inc is far larger — about 7.9× Globus Medical Inc. Class A Common Stock's market cap, and EOG Resources Inc pays a 2.65% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EOG Resources Inc for 59 Days and Globus Medical Inc. Class A Common Stock for 0 Days on average.
| EOG | GMED | |
|---|---|---|
Market Cap | $80.88B | $10.25B |
Volume | 2,507,096 | 1,059,528 |
Sector | Energy | Health |
52-Week High | $154.19 | $96.82 |
52-Week Low | $101.78 | $58.33 |
Typical Hold Time | 59 Days | 0 Days |
Enterprise Value | $84.22B | $9.76B |
Dividend Yield | 2.65% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $153.17, up 1.77% with strong technical momentum and bullish moving averages. The company maintains robust profitability with 25.81% net margins and consistent earnings beats, though revenue declined to $22.58B in 2025. Analyst consensus remains strongly positive with 59% buy ratings and a $163.50 price target, while recent CFO transition and dividend payments highlight stable corporate governance.
EOG presents a compelling value opportunity with attractive valuation multiples (P/E 11.92, EV/EBITDA 6.02) and strong cash generation. Key risks include oil price volatility and capital expenditure intensity, but disciplined capital allocation and projected 2026 revenue growth to $26.6B support upside potential toward analyst targets.
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EOG Resources Inc
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →
